You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
SBC: BOLDEN THERAPEUTICS, INC. Topic: NIAPROJECT SUMMARY There is an enormous need for therapeutics to prevent and treat Alzheimer's disease (AD). Adult Hippocampal Neurogenesis (AHN) is critical for normal learning and memory, but it declines in patients with AD. Work in animal models has underscored the role of AHN in improving cognition in the face of AD pathology. Thus, restoring AHN has emerged as an attractive target for an AD ther ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
A CT-Based Multiparametric Imaging Biomarker for Assessment of Pediatric Interstitial Lung Disease
SBC: Imbio, LLC Topic: NHLBIPROJECT SUMMARY Childhood (diffuse) interstitial lung diseases affects infants, children, and teens and manifests as dyspnea, hypoxemia, and respiratory compromise resulting in high morbidity and mortality or life-long sequelae for survivors. Despite improvements in the understanding of and interventions for pediatric diffuse lung disease in the past 15 years, the current standard-of-care for conf ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Entrepreneurial development award for a novel Alzheimer's disease therapeutic
SBC: BOLDEN THERAPEUTICS, INC. Topic: YThe aging population in the US and globally has led to an urgent need for therapeutics to prevent and treat Alzheimer's disease (AD). Adult Hippocampal Neurogenesis (AHN) is critical for normal learning and memory and declines in patients with AD. Work in animal models has underscored the role of AHN in improving cognition in the face of AD pathology. Thus, restoring AHN has emerged as an attracti ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Automated System for Accurate Determination of Activities of Daily Living for Independently-Living Persons with Alzheimers Disease and Related Dementias
SBC: ASTER LABS, INC. Topic: NIAProject Abstract In this Phase I SBIR project, ASTER Labs will develop and evaluate an innovative system to automatically and accurately detect Activities of Daily Living (ADL) performed by persons with Alzheimer’s disease and related dementias. It will address a current need to equip caregivers and health care providers, including physicians and cognitive rehabilitation therapists, with reliabl ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Joyuus: A Web-based Tool for Postpartum Care Self-care to Address the Complex Needs of Underserved Women
SBC: JOYUUS, LLC Topic: 100PROJECT SUMMARY/ABSTRACT In the United States, the postpartum period is a critical time for both maternal and child health; the US maternal mortality rate is the highest among other developed, high-income countries. More than half of all maternal deaths occur postpartum, from one day to one year after birth.1-9 There are vast racial and ethnic disparities in maternal mortality and severe morbidity ...
SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Home-Based Parent-Child Intervention to Enhance Executive Function
SBC: Koronis Biomedical Technologies Corp. Topic: 104Abstract Koronis Biomedical Technologies (KBT) and its collaborators propose to develop and fully validate a low-cost, developmentally appropriate, smartphone-based cognitive intervention for young children. The proposed intervention seeks to address the needs of families with young children identified with deficits in Executive Function (EF), a critical set of cognitive processes associated with ...
SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Minority and Underserved Youth Learning about Concussions through Virtual Environments
SBC: MOAI TECHNOLOGIES, LLC Topic: NIMHDAbstract A 2019 study from the CDC estimated 812,000 children (age 17 or younger) were treated in U.S. emergency departments for concussion or Traumatic Brain Injury (TBI), alone or in combination with other injuries in 2014. Another recent study, which specifically focused on children’s sports and recreation-related TBIs found the number of related emergency department visits averaged more than ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals with Alzheimer Disease
SBC: INNOVATIVE DESIGN LABS INC Topic: YProject Summary/Abstract Proposed is a sleep monitoring system specifically designed for care providers of persons with Alzheimer’s disease and Alzheimer’s Disease Related Dementias (AD/ADRD) to monitor sleep disturbances and trends. Significance: Studies indicate that approximately 1 in 3 patients with AD/ADRD suffer from sleep and other nighttime disturbances such as insomnia and disruption ...
SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent
SBC: Vergent Bioscience, Inc. Topic: 102PROJECT SUMMARY/ABSTRACT More than 228,000 people in the United States will receive a lung cancer diagnosis this year. Only 14%-49% of early-stage patients survive at least 5 years after their diagnosis, and the survival rates fall below 5% for patients with advanced-stage IIIB or IV. Tumor recurrence after resection is a critical factor influencing these poor prognoses. If any cancerous tissue is ...
SBIR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Hypoglycemia Vagal Nerve Stimulation Therapy (HVNS Therapy)
SBC: RESHAPE LIFESCIENCES INC Topic: 200Project Summary/Abstract 30.3 million Americans are diabetic w/ 1.5 million new cases per year. Hypoglycemia negatively affects diabetics. The average type 1 diabetic experiences 2 symptomatic hypoglycemia episodes/week. Severe hypoglycemia (need for 3rd party assistance) results in 1.0 – 1.7 episodes per patient per year. Annually, 73% of insulin dependent type 2 diabetics experience hypoglycem ...
SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health